Long-term outcomes by clinical and molecular risk stratification in patients with medulloblastoma receiving risk-adapted therapy

Med 2026

View at publisher
Authors: Hailong Liu, Ying Su, Jiao Zhang, Xuan Chen, Kaiwen Deng, Lei Chen, Jin Feng, Xifeng Wu, Craig Daniels, Yanong Li, Jing Zhang, Yahui Zhao
+21 more Yanfeng Shi, Fei Liu, Zhaoyang Feng, Dongyang Wang, Dongming Han, Wei Wang, Ming Wang, Junping Zhang, Xueling Qi, J. Li, Jian Gong, Wei Liu, Yongji Tian, Yongji Tian, Rui Chen, Tao Jiang, Michael D. Taylor, Chunde Li, Yu Tian, Yu Tian, Hailong Liu
DOI: 10.1016/j.medj.2026.101076
Cited by: 1
References: 45

Fields of Study & Subjects

Glioma Diagnosis and Treatment PARP inhibition in cancer therapy Cancer Lipids and Metabolism

Publication details

Journal / source
Med
Publisher
Elsevier BV
Volume
7
Issue
5
Pages
101076–101076
Publication date
27 March 2026
Language
EN